SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019892
Filing Date
2022-05-12
Accepted
2022-05-12 16:31:36
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxdx-10q_20220331.htm   iXBRL 10-Q 1634463
2 EX-31.1 rxdx-ex311_6.htm EX-31.1 20876
3 EX-31.2 rxdx-ex312_8.htm EX-31.2 20604
4 EX-32.1 rxdx-ex321_9.htm EX-32.1 10269
5 EX-32.2 rxdx-ex322_7.htm EX-32.2 10049
  Complete submission text file 0001564590-22-019892.txt   6904703

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20220331.xsd EX-101.SCH 64547
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20220331_cal.xml EX-101.CAL 44839
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20220331_def.xml EX-101.DEF 215758
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20220331_lab.xml EX-101.LAB 464526
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20220331_pre.xml EX-101.PRE 376130
63 EXTRACTED XBRL INSTANCE DOCUMENT rxdx-10q_20220331_htm.xml XML 1047292
Mailing Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121
Business Address 3050 SCIENCE PARK ROAD SAN DIEGO CA 92121 (858) 422-4300
Prometheus Biosciences, Inc. (Filer) CIK: 0001718852 (see all company filings)

IRS No.: 814282653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40187 | Film No.: 22918371
SIC: 2834 Pharmaceutical Preparations